Billabong International

Similar documents
Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Platinum Asset Management

SG Fleet Group. Another UK acquisition. Earnings and target price revision

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

Generation Healthcare REIT

Vista Group International

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

Healthcare. Currency adjustments AUSTRALIA. Event. Impact. Outlook COH 8.0% RMD 6.9% CSL 6.0% ANN 5.0% SHL 2.6%

SingTel. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Outperform.

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Auckland International Airport

Sims Metal Management

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Automotive Holdings Group

Fisher & Paykel Healthcare

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Australian Banks. Funding markets open for now

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Aussie Macro Moment. Budget 16/17 careful consolidation AUSTRALIA. Event. Impact. Outlook

Tox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

Australian Banks. Money Talks vertically challenged AUSTRALIA. Inside. Majors average short positions and banks index

Whitehaven Coal. China outlook drives impairments A$1.04 AUSTRALIA. Event. Impact. Earnings and target price revision.

Oil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Aventus Retail Property Fund

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Meridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Bendigo and Adelaide Bank

Australian Mobile Market

National Australia Bank

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Coca-Cola Amatil. Not as fizzy as it looks A$8.78 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August

Austal. Retail take up 62% Earnings and target price revision. Price catalyst. Action and recommendation

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision.

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA

National Australia Bank

Spotless Group Holdings

Generation Healthcare REIT All about spread Event

Australian Banks. Insolent Insolvencies

Nuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Senex Energy Production and revenue unsurprised, cash builds on lower capex

Fisher & Paykel Healthcare

NEW ZEALAND Price Valuation NZ$ 1.74 Event 12-month target NZ$ month TSR % -10.1

Orocobre. Upside exposure fading. Earnings and target price revision. Price catalyst. Catalyst: Update on projects or Q1 report

Aust. General Insurance

Kingsgate Consolidated

CSL: Global plasma report

Origin Energy. 4Q Production. ORG reported its 4 th quarter production report, following on ConocoPhilips quarterly result.

Carsales.com. Motoring along nicely A$10.23 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Oz Minerals. On track to meet guidance A$6.51 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Tatts Group. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Underperform on valuation grounds.

ANZ Bank. The Dis-Associates. Earnings and target price revision. No change. Price catalyst. Catalyst: 3Q15 Trading Update. Action and recommendation

3P Learning. Coming to America... A$2.55 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

The quiet achiever. Earnings and target price revision. Price catalyst. Catalyst: July building approvals 30 August. Action and recommendation

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

Super Retail Group (SUL AU) Are we there yet?

Genworth Mortgage Insurance Australia

Iron Mountain. US$10 worth Recalling at investor day US$31.83 UNITED STATES. Event. Impact. Earnings and target price revision.

CIMIC Group. Earnings and target price revision. No change. Price catalyst. Catalyst: Q1 earnings 13 April. Action and recommendation

PanAust. Larger impairment and dividend cut A$1.35 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Oz Minerals. Solid start to the year A$5.62 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Downer EDI Two out of three ain t bad Event

Builders Barometer. Rising damp AUSTRALIA. Event. Impact. Outlook

Perseus Mining. Revised Sissingué plan A$0.31 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

SingTel. Optus rises A$3.98 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Australian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA

Fortescue Metals Group

Earnings and target price revision. Price catalyst. Action and recommendation

JB Hi-Fi & Harvey Norman

Genesis Energy. A 9% FCF yield and you call underperform? NZ$1.71 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Karoon Gas. What a difference a day makes A$1.63 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

US Economics. State of the Union Growth, rates, and equities NORTH AMERICA. In a nutshell. Our key views on growth, policy, and rates

Pilbara Minerals (PLS AU) Ramp-up gaining traction

ANZ Bank. What execution risk? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017.

Filling in the gaps. Earnings and target price revision. Price catalyst. Action and recommendation

Premier Investments. Making a move? A$14.18 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Bendigo and Adelaide Bank

Coca-Cola Amatil. Earnings and target price revision. Price catalyst. Action and recommendation

Horizon Oil Gas commercialisation progressing Event

Fisher & Paykel Healthcare

A mixed bag. Earnings and target price revision. Price catalyst. Catalyst: FY14 results. Action and recommendation

AUSTRALIA Price Valuation A$ 7.52 Event 12-month target A$ month TSR % +3.4

Dexus Property Group. Infra driving industrial demand A$9.94 AUSTRALIA. Event. Impact. Earnings and target price revision.

Silver Lake Resources

Monash IVF Group. Share losses compound pain A$1.40 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

MMG. A year of consolidation in 2017 AUSTRALIA/HONG KONG. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Independence Group NL

Goodman Fielder. A useful strategy. Earnings and target price revision. Price catalyst. Catalyst: 1H13 result. Action and recommendation

Nine Entertainment Co.

APA Group. Earnings and target price revision. Price catalyst

Kiwi Property Group. Land banking for the future NZ$1.43 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Transcription:

AUSTRALIA BBG AU Price (at 06:10, 27 Aug 2012 GMT) A$1.35 Volatility index Very High GICS sector Consumer Durables & Apparel Market cap A$m 644 30-day avg turnover A$m 4.4 Number shares on issue m 478.9 Investment fundamentals Year end 30 Jun 2012A 2013E 2014E 2015E Revenue m 1,550.7 1,345.7 1,346.4 1,374.9 EBIT m 52.6 74.9 90.6 91.0 Reported profit m -279.3 53.0 61.5 65.0 Adjusted profit m 33.5 53.0 61.5 65.0 Gross cashflow m 80.2 102.1 112.0 117.2 CFPS 24.9 27.9 23.5 24.6 CFPS growth % -49.9 11.7-15.7 4.6 PGCFPS x 5.4 4.8 5.7 5.5 PGCFPS rel x 0.62 0.66 0.86 0.86 EPS adj 10.4 14.5 12.9 13.6 EPS adj growth % -71.9 38.7-10.9 5.8 PER adj x 12.9 9.3 10.4 9.9 PER rel x 0.93 0.80 1.05 1.05 Total DPS 2.4 0.0 0.0 0.0 Total div yield % 1.8 0.0 0.0 0.0 Franking % 0 nmf nmf nmf ROA % 2.3 3.6 4.4 4.2 ROE % 3.0 5.0 5.5 5.5 EV/EBITDA x -2.8 6.5 5.7 5.6 Net debt/equity % 15.7 11.8 3.7-3.6 P/BV x 0.4 0.6 0.6 0.5 BBG AU vs Small Ordinaries Source: FactSet, Macquarie Research, August 2012 (all figures in AUD unless noted) 28 August 2012 Macquarie Securities (Australia) Limited Deep dives everywhere Event Billabong (BBG) reported a FY12 loss of $275.6m. Excluding significant items loss of $516.9m and profit on sale of discontinued business of $206m, FY12 NPAT was $33.5m compared to $119.1m in pcp. No final dividend was declared. We discuss. Impact At the group level, on a continuing business basis and before ISI s, reported revenue declined by 7.3%, EBITDA declined by 52% and NPAT declined by 63%. However, when measured on a continuing and discontinued basis, sales revenue declined by 7.9%, EBITDA decline by $84m (40.9%) and NPAT decline by 74.3%. The exact decline in contribution from company-owned retail was not disclosed but based on commentary from management that stand-alone retail would be break-even we estimate c. $50m of the $84m decline in EBITDA could be attributable to retail. Given the significant size of company-owned retail (c. $719m in sales in FY12) management addressed strategies to fix the business model in its inherent value presentation. While it appears to be a good sales document there was substance in new CEO Inman s assessment of the company s weakness in retail and opportunities to improve the business. In addition to closing an additional 82 stores in FY13 (operating 634 at June 2012) it was revealed that currently 20% of stores are loss-making and a further 20% are just covering their return on capital. Management are looking at ways to improve stores to lift them to the next tier of profitability via improved visual merchandising and high-impact, low-cost store touch ups. While they have shut stores where it was economic to do so, the remaining unprofitable stores they hope to lift profitability to a neutral ROC outcome. They also revealed that they have brought in Colin Haggerty (from Target Australia and extensive UK retail experience) to bolster Billabong s retail expertise. Management identified the earnings prize over the next three years as lifting EBITDA from $84m pro forma in FY12 to c$155m in FY16. Earnings upside is expected to be driven by modest revenue growth, cost and efficiency gains such as simplifying the business, globalising and integrating the supply chain and exiting uneconomical retail stores. Sales-led initiatives include leveraging of brands as well as building out the e-commerce platform into Europe. FY net cash flow from operating activities rose to $78m reflecting working capital releases compared to pcp. Earnings and target price revision FY13E, 14E and 15E EPS -12% and -7%, respectively. Price catalyst Due to research restrictions, Macquarie cannot advise its valuation on BBG AU at present. Action and recommendation Restricted. Please refer to the important disclosures and analyst certification on inside back cover of this document, or on our website www.macquarie.com/disclosures.

Analysis Billabong reported its FY12 results in three different formats. In the table below is the consolidated income statement on a continuing business basis per the Financial Report. The financials are presented as if Nixon (partial divestment and now an associate) were eliminated for the full year. What is interesting about this analysis is that the significant deterioration in EBIT has come from overheads associated with the retail business and not the trading line, eg, gross profit. However we do note an ISI of $73m was booked against the GP line in the accounts (we remove for comparative purposes) and it relates to inventory sold over FY12 and to be sold over FY13. Fig 1 FY12 P&L on a continuing business basis FY11 FY12 chg $ chg % Sales revenue $m 1558.5 1444.1-114.4-7.3% COGS $m 728.3 691.6-36.7-5.0% Gross profit $m 830.2 752.5-77.7-9.4% Other income $m 5.1 5.1-0.1-1.0% SG&A $m 564.7 527.6-37.0-6.6% Other expenses $m 144.8 195.9 51.2 35.4% Associates $m 0.3 0.3 EBIT $m 125.9 34.2-91.6-72.8% Finance costs $m 37.2 41.0 3.8 10.1% PBT $m 88.7-6.7-95.4-107.6% Tax expense $m -3.8-40.0-43.8 NPAT $m 92.5 34.3-58.3-63.0% ISIs $m -516.9-516.9 Discontinued business $m 25.5 206.0 180.5 non controlling interest $m 1.1 1.0-0.1 Reported NPAT $m 119.1-275.6-394.8-331.3% Ratios (%) chg $ chg bps COGS % 46.7% 47.9% - 46 GP margin % 53.3% 52.1% - 53 SG&A % 36.2% 36.5% - 36 EBIT margin % 8.1% 2.4% - 8 Effective tax Rate % 4.3% 593.4% 2 Depreciation $m 37.8 44.6 6.8 17.9% EBITDA $m 163.7 78.8-84.9-51.9% EBITDA margin % 10.5% 5.5% - 10 Source: BBG, Macquarie Research, August 2012 BBG also produced a group and regional profit and loss on a continuing and discontinued basis. On a reported basis sales revenue declined 7.9% to $1.55bn (-5.0% on a constant currency basis) and EBITDA declined 32% to $130m (constant currency EBITDA declined 30%). Adjusted EBITDA (before significant and exceptional items) in FY12 was $120m. The elimination of Nixon revenue an EBITDA across FY12 reduced sales revenue by $111.6m (FY11 $129m) and EBITDA by $36.2m (FY11 $42.6m). Around the regions, on a continuing and discontinued basis, revenue fell in all regions except Australia and EBITDA fell between 20% and 50% in all regions. The split between wholesale and regional performance is shown in a table below but not the rate of change across FY12. It would appear, however, based on disclosure in FY11, retail EBITDA has declined by c. $50m to a breakeven basis on a stand-alone measure, eg, sales of product from BBG wholesale to retail at full margin. This analysis doesn t necessarily mean BBG wholesale profitability is unchanged as we cannot be sure about the impact the ISI in FY12 COGS has had on either business. It is also an unusual entry how do you sell inventory below costs but create a debit to COGs? What do you credit? Goodwill? There is also an unknown positive impact on FY13 profit and loss as redundant old stock is liquidated and the provision released. 28 August 2012 2

Fig 2 FY12 P&L on a continuing and discontinuing basis Constant currency versus reported results FY11 FY12 chg $ chg % Constant currency Sales revenue $m 1,631.5 1,550.6-80.9-5.0% EBITDA $m 186.9 130.4-56.5-30.2% NPAT $m 115.9-275.6-391.5-337.8% EBITDA margin % 11.5% 8.4% Regional Sales Revenue FY11 FY12 chg $ chg % Americas $m 843.7 750.3-93.4-11.1% Europe $m 337.6 278.1-59.5-17.6% Australasia $m 501.9 522.3 20.4 4.1% Total sales revenue* $m 1,683.3 1,550.7-132.6-7.9% EBITDA $m Americas $m 80.2 59.7-20.5-25.6% Europe $m 54.2 24.2-30.0-55.4% Australasia $m 55.2 33.8-21.4-38.8% Other $m 2.2 2.9 0.7 31.2% Total EBITDA $m 191.8 120.6-71.2-37.1% Margins bps Americas % 9.5% 8.0% - 155 Europe % 16.1% 8.7% - 735 Australasia % 11.0% 6.5% - 453 Total EBITDA % 11.4% 7.8% - 362 *excludes 3rd party royalties Source: BBG. Macquarie Research, August 2012 BBG released a wholesale/retail split for the business for FY12. The eliminations adjustment reflects duplicated profit between the two businesses but what is not disclosed is how the amount is allocated. When queried CFO White acknowledged BBG retail would be break even or perhaps a small loss. Fig 3 BBG PL on a continuing and discontinuing basis split between wholesale and retail Wholesale Retail Eliminations Adjusted Consolidated Sales $m 1069.5 719.6-238.5 1550.6 EBITDA (pre-global costs) $m 199.9 65.1-104.1 160.9 EBITDA margin % 18.7% 9.0% 10.4% EBIT (pre-global costs) $m 180.6 40.0-104.1 116.5 EBIT Margin % 16.9% 5.6% 7.5% Global Costs $m 31.3 9.0 40.3 EBITDA (post-global costs) $m 168.6 56.1-104.1 120.6 EBITDA margin (post global costs) % 15.8% 7.8% 7.8% EBIT (post global costs) $m 149.0 30.9-104.1 75.8 EBIT margin (post global costs) % 13.9% 4.3% 4.9% Source: BBG, Macquarie Research, August 2012 Transformation strategy diving deep Management presented the findings from their two-month review of the business and the plans to stabilise Billabong s earnings and return it to growth. First in identifying the prize, management estimated the market size (in Fig 4) of the global boardsports retail market at c$15bn, of which BBG share is c.15%. Growth in this segment of the market over 2009 to 2012 was estimated to have grown c.4% compounded annually. Management also identified the earnings prize over the next three years as c$155m+ of incremental EBITDA as shown in Fig 5. Many of the items identified are cost and efficiency gains such as simplifying the business, globalising and integrating the supply chain and exiting uneconomical retail stores. The sales-led initiatives are leveraging of brands as well as building out the e-commerce platform into Europe. 28 August 2012 3

Fig 4 Serving a c.$15bn boardsports market Fig 5 Targeting $155m of incremental EBITDA by FY16 Source: Company slides, Macquarie Research, August 2012 Source: Company slides, Macquarie Research, August 2012 Management s study has also concluded that Brand Billabong currently only serves ~19% of the boardsport market (Board Sports participants and Board Sports fanatics). They are missing c.34% of the market (being the Active Lifestyle) who have the same mindset as the core Billabong customer, however, do not have the time or frequency of participation. Therefore, management believes they can target 53% (i.e., a further 34%) of consumers without impacting the core customer through loss of brand authenticity. Trade feedback from boardsports store owners has been that just c.10% of customers are participants and the rest are not, thus BBG is already serving that market. Further, Brand Billabong was shown to have high brand awareness (86% in Australia, although just 47% in USA) although management were not happy with the conversion i.e., only 39% of Australians and 29% of Americans who are aware of the brand actually made a purchase in the last twelve months. Other brands such as Element, Dakine and RVCA had conversions rating between 40-50% that management were pleased with. Based on these metrics, Australia s conversion doesn t appear unreasonable and realistically it is just Brand Billabong s conversion in the USA that falls short. Fig 6 Billabong to target 53% of consumers Fig 7 High Billabong awareness, low conversion Source: Company slides, Macquarie Research, August 2012 Source: Company slides, Macquarie Research, August 2012 Quick wins within the next few years involve a simplification of the business with management expecting to add an incremental c$10m. These initiatives involve identifying a tail of styles, suppliers and customers that add cost and complexity to the business but do not make a meaningful contribution to sales. Examples were given that 46% of suppliers represent just 1% of purchases, 33% of customers represent just 1% of sales and 34% of styles represent just 1% of sales. 28 August 2012 4

Management indicated that they will reduce their style range by c.15% in FY13 and a further 15% in FY14. We wonder if a reduction in range will impact the brands, drive a mass market perception and have less niche product to offer to maintain brand authenticity. Fig 8 Quick wins via simplification worth c$10m Fig 9 Lifting store performance Source: Company slides, Macquarie Research, August 2012 Source: Company slides, Macquarie Research, August 2012 It was revealed that currently 20% of stores are loss-making and a further 20% are just covering their return on capital. Management are looking at ways to improve stores to lift them to the next tiering of profitability via improved visual merchandising and high-impact, low-cost store touch-ups. While they have shut stores where it was economic to do so, the remaining unprofitable stores they hope to lift profitability to a neutral ROC outcome. They also revealed that they have brought in Colin Haggerty (from Target Australia and extensive UK retail experience) to bolster Billabong s retail expertise. Fig 10 Supply chain benchmarking Source: Company slides, Macquarie Research, August 2012 A benchmarking exercise was conducted on Billabong s supply chain vs industry peers to compare vs industry averages and best-in-practice and highlighted the inefficiencies in Billabong s supply chain. Many of the inefficiencies were caused due to poor integration of acquired brands as well as poor global systems to monitor, measure and manage supply chain processes. Management expect to gain c$25m from properly integrating and globalising the supply chain by improving absolute costs and also having short lead times and faster inventory turns. 28 August 2012 5

Important disclosures: Recommendation definitions Macquarie - Australia/New Zealand Outperform return >3% in excess of benchmark return Neutral return within 3% of benchmark return Underperform return >3% below benchmark return Benchmark return is determined by long term nominal GDP growth plus 12 month forward market dividend yield Macquarie Asia/Europe Outperform expected return >+10% Neutral expected return from -10% to +10% Underperform expected return <-10% Macquarie First South - South Africa Outperform expected return >+10% Neutral expected return from -10% to +10% Underperform expected return <-10% Macquarie - Canada Outperform return >5% in excess of benchmark return Neutral return within 5% of benchmark return Underperform return >5% below benchmark return Macquarie - USA Outperform (Buy) return >5% in excess of Russell 3000 index return Neutral (Hold) return within 5% of Russell 3000 index return Underperform (Sell) return >5% below Russell 3000 index return Volatility index definition* This is calculated from the volatility of historical price movements. Very high highest risk Stock should be expected to move up or down 60 100% in a year investors should be aware this stock is highly speculative. High stock should be expected to move up or down at least 40 60% in a year investors should be aware this stock could be speculative. Medium stock should be expected to move up or down at least 30 40% in a year. Low medium stock should be expected to move up or down at least 25 30% in a year. Low stock should be expected to move up or down at least 15 25% in a year. * Applicable to Australian/NZ/Canada stocks only Recommendations 12 months Note: Quant recommendations may differ from Fundamental Analyst recommendations Financial definitions All "Adjusted" data items have had the following adjustments made: Added back: goodwill amortisation, provision for catastrophe reserves, IFRS derivatives & hedging, IFRS impairments & IFRS interest expense Excluded: non recurring items, asset revals, property revals, appraisal value uplift, preference dividends & minority interests EPS = adjusted net profit / efpowa* ROA = adjusted ebit / average total assets ROA Banks/Insurance = adjusted net profit /average total assets ROE = adjusted net profit / average shareholders funds Gross cashflow = adjusted net profit + depreciation *equivalent fully paid ordinary weighted average number of shares All Reported numbers for Australian/NZ listed stocks are modelled under IFRS (International Financial Reporting Standards). Recommendation proportions For quarter ending 30 June 2012 AU/NZ Asia RSA USA CA EUR Outperform 55.67% 61.00% 53.43% 42.58% 69.23% 46.60% (for US coverage by MCUSA, 9.05% of stocks followed are investment banking clients) Neutral 30.50% 22.11% 36.99% 52.41% 28.02% 33.69% (for US coverage by MCUSA, 8.14% of stocks followed are investment banking clients) Underperform 13.83% 16.89% 9.59% 5.01% 2.75% 19.71% (for US coverage by MCUSA, 0.45% of stocks covered are investment banking clients) Company Specific Disclosures: Macquarie and its affiliates collectively and beneficially own or control 1% or more of any class of Limited's equity securities. Macquarie Bank Limited makes a market in the securities in respect of Limited. The analyst and/or associated parties own or have other interests in securities issued by BBG. Macquarie Research is restricted as a result of Macquarie's involvement in the discussions with a potential bidder for as announced by to the ASX on 17 Feb 2012. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures. Analyst Certification: The views expressed in this research reflect the personal views of the analyst(s) about the subject securities or issuers and no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research receives compensation based on overall revenues of Macquarie Group Ltd (ABN 94 122 169 279, AFSL No. 318062) ( MGL ) and its related entities (the Macquarie Group ) and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. General Disclosure: This research has been issued by Macquarie Securities (Australia) Limited (ABN 58 002 832 126, AFSL No. 238947) a Participant of the Australian Securities Exchange (ASX) and Chi-X Australia Pty Limited. This research is distributed in Australia by Macquarie Equities Limited (ABN 41 002 574 923, AFSL No. 237504) ("MEL"), a Participant of the ASX, and in New Zealand by Macquarie Equities New Zealand Limited ( MENZ ) an NZX Firm. Macquarie Private Wealth s services in New Zealand are provided by MENZ. Macquarie Bank Limited (ABN 46 008 583 542, AFSL No. 237502) ( MBL ) is a company incorporated in Australia and authorised under the Banking Act 1959 (Australia) to conduct banking business in Australia. None of MBL, MGL or MENZ is registered as a bank in New Zealand by the Reserve Bank of New Zealand under the Reserve Bank of New Zealand Act 1989. Any MGL subsidiary noted in this research, apart from MBL, is not an authorised deposit-taking institution for the purposes of the Banking Act 1959 (Australia) and that subsidiary s obligations do not represent deposits or other liabilities of MBL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of that subsidiary, unless noted otherwise. This research is general advice and does not take account of your objectives, financial situation or needs. Before acting on this general advice, you should consider the appropriateness of the advice having regard to your situation. We recommend you obtain financial, legal and taxation advice before making any financial investment decision. This research has been prepared for the use of the clients of the Macquarie Group and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient, you must not use or disclose this research in any way. If you received it in error, please tell us immediately by return e-mail and delete the document. We do not guarantee the integrity of any e-mails or attached files and are not responsible for any changes made to them by any other person. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction. This research is based on information obtained from sources believed to be reliable, but the Macquarie Group does not make any representation or warranty that it is accurate, complete or up to date. We accept no obligation to correct or update the information or opinions in it. Opinions expressed are subject to change without notice. The Macquarie Group accepts no liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. The Macquarie Group produces a variety of research products, recommendations contained in one type of research product may differ from recommendations contained in other types of research. The Macquarie Group has established and implemented a conflicts policy at group level, which may be revised and updated from time to time, pursuant to regulatory requirements; which sets out how we must seek to identify and manage all material conflicts of interest. The Macquarie Group, its officers and employees may have conflicting roles in the financial products referred to in this research and, as such, may effect transactions which are not consistent with the recommendations (if any) in this research. The Macquarie Group may receive fees, brokerage or commissions for acting in those capacities and the reader should assume that this is the case. The Macquarie Group s employees or officers may provide oral or written opinions to its clients which are contrary to the opinions expressed in this research. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures. 28 August 2012 6